We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$819M
AUM Growth
+$123M
(+18%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
12.29%
Top 10 Holdings %
Top 10 Hldgs %
9.75%
Holding
710
New
168
Increased
162
Reduced
95
Closed
285
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$9.74M |
| 2 |
McDonald's
MCD
|
+$8.2M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$8.03M |
| 4 |
AGN
Allergan plc
AGN
|
+$7.37M |
| 5 |
Henry Schein
HSIC
|
+$6.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$7.17M |
| 2 |
Lam Research
LRCX
|
+$6.99M |
| 3 |
Electronic Arts
EA
|
+$6.98M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
+$6.79M |
| 5 |
Hilton Worldwide
HLT
|
+$6.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.19% |
| 2 | Technology | 15.05% |
| 3 | Consumer Discretionary | 14.44% |
| 4 | Financials | 11.43% |
| 5 | Consumer Staples | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
McDonald's
MCD
$192B
| $8.52M | 1.04% |
54,405
+52,300
| +2,485% | +$8.2M |
|
|
TWX
2
DELISTED
Time Warner Inc
TWX
| $8.52M | 1.04% |
83,134
+13,500
| +19% | +$1.37M |
|
3
JD.com
JD
$41.8B
| $8.5M | 1.04% |
222,599
+110,400
| +98% | +$4.73M |
|
4
Kraft Heinz
KHC
$31.1B
| $8.16M | 1% |
105,200
+69,300
| +193% | +$5.8M |
|
5
Humana
HUM
$45.8B
| $8.04M | 0.98% |
33,000
+22,500
| +214% | +$5.51M |
|
6
Mondelez International
MDLZ
$77.9B
| $7.92M | 0.97% |
194,810
+60,600
| +45% | +$2.57M |
|
7
Aptiv
APTV
$12.2B
| $7.75M | 0.95% |
78,725
+32,200
| +69% | +$3.04M |
|
|
PARA
8
DELISTED
Paramount Global Class B
PARA
| $7.69M | 0.94% |
132,600
+127,100
| +2,311% | +$8.03M |
|
9
AbbVie
ABBV
$454B
| $7.54M | 0.92% |
84,858
+74,400
| +711% | +$5.66M |
|
10
Vertex Pharmaceuticals
VRTX
$122B
| $7.24M | 0.88% |
47,600
+37,600
| +376% | +$5.66M |
|
|
MON
11
DELISTED
Monsanto Co
MON
| $7.09M | 0.87% |
59,181
+26,700
| +82% | +$3.14M |
|
12
CarMax
KMX
$8.29B
| $6.89M | 0.84% |
90,913
+88,800
| +4,203% | +$5.92M |
|
13
Agilent Technologies
A
$38.9B
| $6.73M | 0.82% |
105,006
+95,400
| +993% | +$5.94M |
|
14
Colgate-Palmolive
CL
$73.6B
| $6.54M | 0.8% |
89,700
+32,700
| +57% | +$2.36M |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| $6.5M | 0.79% |
+31,700
| New | +$7.37M |
|
16
Progressive
PGR
$125B
| $6.36M | 0.78% |
131,359
+130,100
| +10,334% | +$6.08M |
|
17
Mastercard
MA
$487B
| $6.33M | 0.77% |
44,800
+39,800
| +796% | +$5.27M |
|
18
NXP Semiconductors
NXPI
$67.6B
| $6.31M | 0.77% |
55,820
+34,200
| +158% | +$3.81M |
|
19
Analog Devices
ADI
$181B
| $6.27M | 0.77% |
72,771
+69,400
| +2,059% | +$5.6M |
|
20
Palo Alto Networks
PANW
$259B
| $6.26M | 0.76% |
260,766
+153,000
| +142% | +$3.48M |
|
|
21
Henry Schein
HSIC
$9.64B
| $6.19M | 0.76% |
96,263
+95,753
| +18,775% | +$6.53M |
|
|
COL
22
DELISTED
Rockwell Collins
COL
| $6.16M | 0.75% |
+47,141
| New | +$5.73M |
|
|
ETFC
23
DELISTED
E*Trade Financial Corporation
ETFC
| $6.12M | 0.75% |
+140,323
| New | +$5.7M |
|
|
AET
24
DELISTED
Aetna Inc
AET
| $6.07M | 0.74% |
38,184
+31,400
| +463% | +$4.91M |
|
25
Cognizant
CTSH
$22.3B
| $6M | 0.73% |
82,708
+44,900
| +119% | +$3.15M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Seven Eight Capital held 710 positions worth $819M, up 18% from $696M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Seven Eight Capital deployed $101M of net new capital in Q3 2017, opening 168 new positions and adding to 162 existing holdings. Its largest new stake was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Constellation Brands, an estimated $6.37M trimmed.
- Seven Eight Capital's largest Q3 2017 buy was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
- Seven Eight Capital added most to McDonald's in Q3 2017, an estimated $8.2M increase.
- Seven Eight Capital's biggest Q3 2017 reduction was Constellation Brands, cutting an estimated $6.37M.
- Seven Eight Capital fully exited Nike in Q3 2017, selling an estimated $7.17M.
- Seven Eight Capital's ten largest holdings make up 9.8% of its $819M portfolio in Q3 2017.
- Seven Eight Capital opened 168 new positions and closed 285 in Q3 2017.
- Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $819M.
Based on Seven Eight Capital's 13F filing for Q3 2017, filed 16 Oct 2017.